WADE CHRISTENSEN: Open Payments
NPI 1386626463 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 41 payments from 14 companies in 2025. Trend: 2023 $1,898 · 2024 $1,098 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $194 |
| Antares Pharma, Inc. | 7 | $151 |
| ABBVIE INC. | 4 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Novo Nordisk Inc | 3 | $53 |
| Lilly USA, LLC | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: FANAPT, XYOSTED, LEQVIO, QULIPTA, ZEPBOUND, VOQUEZNA, Veozah, Auvelity.
Industry payments across ID — which companies pay providers there.
